Landscape of T Cells in NK-AML(M4/M5) Revealed by Single-Cell Sequencing

Author:

Wu Wenqi1,Liang Xiaolin1,Li Huiqun1,Huang Xiaoke1,Wan Chengyao1,Xie Qiongni1,Liu Zhenfang1

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi, China

Abstract

Abstract Normal karyotype acute myeloid leukemia (NK-AML) is a highly heterogeneous malignancy that resides within a complex immune microenvironment, complicating efforts to reveal the interaction between leukemia cells and immune cells. Understanding tumor-infiltrating T cells is crucial to the advancement of immune therapies and the improvement of the prognosis for NK-AML patients. We performed single-cell RNA sequencing on bone marrow cells from 5 NK-AML (M4/M5) patients and 1 normal donor and paired single-cell T cell receptor (TCR) sequencing on single T cells. As a result, we identified 8 T cell clusters based on the gene expression characteristics of each subset in NK-AML and described their developmental trajectories. In NK-AML patients, specific clusters, such as mucosal-associated invariant T cells (MAITs), were preferentially enriched and potentially clonally expanded. These transcriptome and TCR data analyses provide valuable insights and rich resources for understanding the immune environment of NK-AML.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference54 articles.

1. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse;Wang;Cancer Genet Cytogenet,2010

2. Is it important to decipher the heterogeneity of “normal karyotype AML”?;Nimer;Best Pract Res Clin Haematol,2008

3. [Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2017)];Leukemia, Lymphoma Group CSoHCMA;Zhonghua Xue Ye Xue Za Zhi,2017

4. Acute myeloid leukemia: a comprehensive review and 2016 update;De Kouchkovsky;Blood Cancer J,2016

5. Breakthrough of the year 2013;Couzin-Frankel;Cancer immunotherapy Science,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3